General topics
| No. | TOPIC |
|---|---|
| 1 | Haematopoietic Stem Cells |
| 2 | Stem Cell mobilization, Collection and Engineering |
| 3 | CAR-based Cellular Therapy – Preclinical |
| 4 | CAR-based Cellular Therapy – Clinical |
| 5 | Cellular Therapies other than CARs |
| 6 | Gene Therapy |
| 7 | Experimental Transplantation |
| 8 | New Drugs- and Cell-based Immune Therapies |
| 9 | Non-haematopoietic Stem Cells |
| 10 | Regenerative Medicine |
| 11 | Psychological Issues |
| 12 | Pharmacology |
Transplant-specific topics
| no. | TOPIC |
|---|---|
| 13 | Stem Cell Source |
| 14 | Stem Cell Donor |
| 15 | Graft-versus-host Disease – Preclinical and Animal Models |
| 16 | Graft-versus-host Disease – Clinical |
| 17 | Infectious Complications |
| 18 | Non-infectious Early Complications |
| 19 | Non-infectious Late Effects, Quality of Life and Fertility |
| 20 | Conditioning Regimens |
| 21 | Minimal Residual Disease, Tolerance, Chimerism and Immune Reconstitution |
| 22 | Paediatric Issues |
| 23 | Experimental Stem Cell Transplantation |
Disease-specific topics
| no. | TOPIC |
|---|---|
| 24 | Acute Leukaemia |
| 25 | Aplastic Anaemia |
| 26 | Autoimmune Diseases |
| 27 | Myeloproliferative Neoplasm |
| 28 | Granulocyte and Osteoclast Disorders |
| 29 | Haemoglobinopathy |
| 30 | Inborn Errors |
| 31 | Immunodeficiency Diseases and Macrophages |
| 32 | Lymphoma and Chronic Lymphocytic Leukemia |
| 33 | Multiple Myeloma |
| 34 | Myelodysplastic Syndromes |
| 35 | Solid Tumours |
Data Management Group
| no. | TOPIC |
|---|---|
| 36 | Data Management |
Statistics
| no. | TOPIC |
|---|---|
| 37 | Statistics |
Quality Management
| no. | TOPIC |
|---|---|
| 38 | Accreditation |
| 39 | Quality Management |
| 40 | Regulatory Issues |
| 41 | Sharing Best Quality Practices |
Care-specific topics
| no. | TOPIC |
|---|---|
| 42 | Care of the Carer |
| 43 | Complementary Therapies |
| 44 | Donor Issues |
| 45 | Ethical Issues |
| 46 | Impact of New Therapies on Patient Care |
| 47 | Information and Education |
| 48 | Management |
| 49 | Outpatient Developments |
| 50 | Palliative Care |
| 51 | Patient Safety |
| 52 | Psycho-social Issues |
| 53 | Protective Care |
| 54 | Quality of Life |
| 55 | Standards of Care |
| 56 | Survivorship |
| 57 | Symptoms Management |
| 58 | CAR-T or Immune Effector Cells |
| 59 | Quality Management and JACIE |
| 60 | Transplant. CAR-T Coordination and Follow-up |
| 61 | Advanced Nursing Practice |